Medical Research
Als Cure Project Inc
PLEASANTON, CA
Total revenue
$860K
Total expenses
$219K
Net assets
$740K
Grants received
$721K
17 grants
EIN
843289802
Tax year
2024
Mission
The specfic purpose of the Organization shall include without limitation, to lead scientific research focused on the identification of Amyotrophic Lateral Scierosis ALS bio-markers and disease mechanism
Programs
2 programs
ALS and Parkinsons Drug Repurposing ProjectThis project is a validation of previous work funded at Lawrence Livermore National Laboratory through the Livermore Lab Foundation LLF was funded to validate results using the Optum dataset. The goal of this project is to use ML learning to analyze medical records of ALS patients to search for existing approved drugs off-target which might be useful in extending the life of ALS and PD patients. Funding partners included, LLF, Stanford, ALS Network and the RDM Positive Impact Foundation.
UC Campus ALS MeetingSponsored the poster session reception at this 2 day conference for UC ALS researchers and ALS funding agencies at the University of California Livermore Collaboration Campus.
Financials
FY 2024
Revenue
Expenses
People
8 listed
Mike Piscotty
President
—
10 hrs/wk
Stephen Piscotty
VIce President
—
1 hrs/wk
Toni Eslick
Secretary
—
6 hrs/wk
James Gilbreth
Fund Raising Director
—
6 hrs/wk
Barron Wesenberg
Treasurer
—
3 hrs/wk
Andrew Woodward
IT Communications Director
—
3 hrs/wk
Dave Darby
Corporate Sponsorship Director
—
3 hrs/wk
Jim Poole
Strategic Partnership Director
—
3 hrs/wk
Grants received
Showing 17 of 17
Funded by
$721K from 12 funders · 17 grants · 2018–2024
$325K · 2 grants · 2023–2024
$130K · 1 grant · 2020
$91K · 2 grants · 2020–2022
$51K · 1 grant · 2021
$42K · 3 grants · 2021–2024
$20K · 2 grants · 2022–2024
$16K · 1 grant · 2022
$15K · 1 grant · 2019